AU6053898A - A cell-free system of mitochondria-dependent apoptosis, and methods of use ther eof - Google Patents

A cell-free system of mitochondria-dependent apoptosis, and methods of use ther eof

Info

Publication number
AU6053898A
AU6053898A AU60538/98A AU6053898A AU6053898A AU 6053898 A AU6053898 A AU 6053898A AU 60538/98 A AU60538/98 A AU 60538/98A AU 6053898 A AU6053898 A AU 6053898A AU 6053898 A AU6053898 A AU 6053898A
Authority
AU
Australia
Prior art keywords
mitochondria
cell
methods
free system
dependent apoptosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60538/98A
Inventor
Dale E Bredesen
H. Michael Ellerby
Lisa M. Ellerby
Seamus J. Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
La Jolla Institute for Allergy and Immunology
Sanford Burnham Prebys Medical Discovery Institute
Original Assignee
Sanford Burnham Prebys Medical Discovery Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanford Burnham Prebys Medical Discovery Institute filed Critical Sanford Burnham Prebys Medical Discovery Institute
Publication of AU6053898A publication Critical patent/AU6053898A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • G01N33/5079—Mitochondria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96466—Cysteine endopeptidases (3.4.22)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96466—Cysteine endopeptidases (3.4.22)
    • G01N2333/96469—Interleukin 1-beta convertase-like enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU60538/98A 1997-08-04 1998-01-29 A cell-free system of mitochondria-dependent apoptosis, and methods of use ther eof Abandoned AU6053898A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5464397P 1997-08-04 1997-08-04
US60054643 1997-08-04
US91980197A 1997-08-29 1997-08-29
US08919801 1997-08-29
PCT/US1998/001957 WO1999006588A1 (en) 1997-08-04 1998-01-29 A cell-free system of mitochondria-dependent apoptosis, and methods of use thereof

Publications (1)

Publication Number Publication Date
AU6053898A true AU6053898A (en) 1999-02-22

Family

ID=26733297

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60538/98A Abandoned AU6053898A (en) 1997-08-04 1998-01-29 A cell-free system of mitochondria-dependent apoptosis, and methods of use ther eof

Country Status (2)

Country Link
AU (1) AU6053898A (en)
WO (1) WO1999006588A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2421872A1 (en) 2000-09-11 2002-03-14 Institut Pasteur Mechanism of mitochondrial membrane permeabilization by hiv-1 vpr, mimetics of vpr and methods of screening active molecules having the ability to alter and/or prevent and/or mimic the interaction of vpr with ant
US7357928B2 (en) 2002-04-08 2008-04-15 University Of Louisville Research Foundation, Inc. Method for the diagnosis and prognosis of malignant diseases
US7541150B2 (en) 2002-04-08 2009-06-02 University Of Louisville Research Foundation, Inc Method for the diagnosis and prognosis of malignant diseases
DE60331310D1 (en) * 2002-06-26 2010-04-01 Univ Louisville Res Found PROCEDURE FOR APOPTOSE DETECTION
US9260517B2 (en) 2009-11-17 2016-02-16 Musc Foundation For Research Development Human monoclonal antibodies to human nucleolin
ES2690557T3 (en) 2011-06-02 2018-11-21 University Of Louisville Research Foundation, Inc. Nanoparticles conjugated to an antinucleolin agent
WO2016179394A1 (en) 2015-05-05 2016-11-10 Malik Mohammad Tariq Anti-nucleolin agent-conjugated nanoparticles as radio-sensitizers and mri and/or x-ray contrast agents

Also Published As

Publication number Publication date
WO1999006588A1 (en) 1999-02-11

Similar Documents

Publication Publication Date Title
AU1921599A (en) Demodulation system and method therefor
AU4597297A (en) Trans-sodium crocetinate, methods of making and methods of use thereof
AU2440997A (en) Calixpyrroles, calixpyridinopyrroles and calixpyridines
AU3742197A (en) Knowledge management system and method
AU1151297A (en) Pressure sensitive ink means, and methods of use
AU6864698A (en) Surgical template and surgical method employing same
AU2055997A (en) Method and system for the secure communication of data
AU8560598A (en) Optical disk, reproduction apparatus, and reproduction method
AU4416396A (en) Restaurant management system
AU8591398A (en) Workflow systems and methods
AU1295899A (en) System and method for tracking with user modifiable interface
AU2800497A (en) Interrupt modulation method and appratus
AU5201599A (en) Secure communication hub and communication method
AU6060596A (en) Demodulator, modulation and demodulation system, and demodulation method
AU1756799A (en) Epoxidation catalyst, its use and epoxidation method in the presence of said catalyst
AU3818097A (en) Knowledge management system and method
AU6530098A (en) Iq modulator, and associated method
AU2389600A (en) Reservoir-and-filter system and method of use
AUPO163696A0 (en) Lighting devices, methods of constructing lighting devices and methods of operating lighting devices
AU4585397A (en) Bearing having micropores, and design method thereof
AU9194098A (en) Method and arrangement for demodulating data symbols
AU8662198A (en) Activated forms of notch and methods based thereon
AU3287897A (en) Modified polysiloxane catalysts and a method of using the same
AU5497198A (en) Cutting method and cutting fluid
AU6053898A (en) A cell-free system of mitochondria-dependent apoptosis, and methods of use ther eof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase